Immune checkpoint blockade has transformed management of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC), yet efforts to integrate immunotherapy into curative chemoradiation have failed to improve outcomes. We conducted a narrative review of English-language literature published between 2015 and 2...
Henry Freeman, C. Rawson, Nadir Al-Saidi et al.· Exploration of Targeted Anti...· 0 citations
Aneurysmal subarachnoid hemorrhage (SAH) is a neurologic emergency in which delayed or missed diagnosis can result in substantial morbidity and mortality. In patients who present with clinical features concerning for SAH but have a normal or non-diagnostic non-contrast head computed tomography (CT), the optimal next di...
C. Rawson, Yashieta Somani, M. Karsy et al.· Frontiers in Neurology· 0 citations
BACKGROUND
Cancer has traditionally been framed as a cell-intrinsic genetic disease and, more recently, as a disorder of the tumor microenvironment (TME). An emerging third view reframes malignancy as a systems-level neuroimmune disorder, in which neurons, glia, immune cells, and tumor cells form a continuously communi...
Agastya Mittal, C. Rawson, Jaime Tellez et al.· Neuroimmunomodulation· 0 citations
BBB microdisruption, particularly through FUS with microbubbles, represents a transformative platform for central nervous system gene therapy, and continued research is needed to standardize treatment protocols, characterize long-term safety, and facilitate broader clinical translation.
M. Rashad, Agastya Mittal, Srivardhan Chirasani et al.· Journal of Molecular Patholo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.